Skip to main content
. 2022 Nov 15;41(4):816–825. doi: 10.1200/JCO.22.00575

TABLE 3.

Treatment-Emergent Adverse Events Reported in at Least 20% of Patients in Either Cohort (safety analysis set)

graphic file with name jco-41-816-g006.jpg